These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28508433)

  • 1. An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells.
    Khan A; Southworth T; Worsley S; Sriskantharajah S; Amour A; Hessel EM; Singh D
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):932-940. PubMed ID: 28508433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
    Gupta V; Khan A; Higham A; Lemon J; Sriskantharajah S; Amour A; Hessel EM; Southworth T; Singh D
    Int Immunopharmacol; 2016 Jun; 35():155-162. PubMed ID: 27049289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.
    Southworth T; Plumb J; Gupta V; Pearson J; Ramis I; Lehner MD; Miralpeix M; Singh D
    Respir Res; 2016 Oct; 17(1):124. PubMed ID: 27716212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease.
    Marwick JA; Caramori G; Casolari P; Mazzoni F; Kirkham PA; Adcock IM; Chung KF; Papi A
    J Allergy Clin Immunol; 2010 May; 125(5):1146-53. PubMed ID: 20381852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions.
    Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
    Mol Immunol; 2008 Jul; 45(12):3419-27. PubMed ID: 18471882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
    Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease.
    Kaur M; Smyth LJ; Cadden P; Grundy S; Ray D; Plumb J; Singh D
    Respir Res; 2012 Mar; 13(1):20. PubMed ID: 22417244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
    Sriskantharajah S; Hamblin N; Worsley S; Calver AR; Hessel EM; Amour A
    Ann N Y Acad Sci; 2013 Mar; 1280():35-9. PubMed ID: 23551101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
    Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.
    Forsslund H; Yang M; Mikko M; Karimi R; Nyrén S; Engvall B; Grunewald J; Merikallio H; Kaarteenaho R; Wahlström J; Wheelock ÅM; Sköld CM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():35-48. PubMed ID: 28053515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease.
    Barceló B; Pons J; Fuster A; Sauleda J; Noguera A; Ferrer JM; Agustí AG
    Clin Exp Immunol; 2006 Sep; 145(3):474-9. PubMed ID: 16907916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with AM3 restores defective T-cell function in COPD patients.
    Reyes E; Prieto A; de la Hera A; de Lucas P; Alvarez-Sala R; Alvarez-Sala JL; Alvarez-Mon M
    Chest; 2006 Mar; 129(3):527-35. PubMed ID: 16537848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased airway T lymphocyte microparticles in chronic obstructive pulmonary disease induces airway epithelial injury.
    Qiu Q; Dan X; Yang C; Hardy P; Yang Z; Liu G; Xiong W
    Life Sci; 2020 Nov; 261():118357. PubMed ID: 32861794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K
    Allen RA; Brookings DC; Powell MJ; Delgado J; Shuttleworth LK; Merriman M; Fahy IJ; Tewari R; Silva JP; Healy LJ; Davies GCG; Twomey B; Cutler RM; Kotian A; Crosby A; McCluskey G; Watt GF; Payne A
    J Pharmacol Exp Ther; 2017 Jun; 361(3):429-440. PubMed ID: 28442583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
    Knobloch J; Yakin Y; Körber S; Grensemann B; Bendella Z; Boyaci N; Gallert WJ; Yanik SD; Jungck D; Koch A
    Eur J Pharmacol; 2016 Oct; 788():294-305. PubMed ID: 27343379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma.
    Stankiewicz W; Dabrowski MP; Chcialowski A; Plusa T
    Mediators Inflamm; 2002 Oct; 11(5):307-12. PubMed ID: 12467523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
    Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
    Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between subpopulations of regulatory T cells in COPD.
    Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
    Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
    Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo--effects of anti-inflammatory pharmacotherapy.
    Prause O; Bossios A; Silverpil E; Ivanov S; Bozinovski S; Vlahos R; Sjöstrand M; Anderson GP; Lindén A
    Pulm Pharmacol Ther; 2009 Jun; 22(3):199-207. PubMed ID: 19121406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.